Accurate Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
10,275
+1,331
+15% +$175K 0.13% 177
2026
Q1
$1.24M Buy
8,944
+1,091
+14% +$153K 0.15% 152
2025
Q4
$951K Buy
7,853
+257
+3% +$31.2K 0.12% 184
2025
Q3
$900K Buy
7,596
+1,291
+20% +$147K 0.12% 184
2025
Q2
$722K Buy
6,305
+1,591
+34% +$169K 0.11% 200
2025
Q1
$489K Buy
4,714
+1,258
+36% +$130K 0.09% 212
2024
Q4
$311K Buy
3,456
+230
+7% +$20.7K 0.06% 288
2024
Q3
$277K Sell
3,226
-131
-4% -$10K 0.06% 295
2024
Q2
$238K Buy
3,357
+54
+2% +$3.6K 0.06% 287
2024
Q1
$221K Sell
3,303
-2,590
-44% -$199K 0.06% 268
2023
Q4
$503K Sell
5,893
-424
-7% -$33K 0.16% 135
2023
Q3
$508K Buy
6,317
+794
+14% +$61.1K 0.16% 135
2023
Q2
$426K Sell
5,523
-559
-9% -$44.6K 0.13% 156
2023
Q1
$502K Buy
6,082
+704
+13% +$58.3K 0.17% 133
2022
Q4
$469K Sell
5,378
-42,847
-89% -$3.39M 0.17% 107
2022
Q3
$3.19M Buy
48,225
+19,618
+69% +$1.24M 1.33% 16
2022
Q2
$1.79M Buy
28,607
+25,102
+716% +$1.55M 0.98% 16
2022
Q1
$208K Buy
+3,505
New +$224K 0.09% 165

Other funds holding GILD

Accurate Wealth Management's GILD Position: Q2 2026 in Review

Accurate Wealth Management increased its Gilead Sciences (GILD) stake by 15% in Q2 2026, buying an estimated $175K and bringing the position to 10,275 shares worth $1.33M. The position accounts for 0.13% of the portfolio, ranked #177.

Accurate Wealth Management first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.19M in Q3 2022. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Accurate Wealth Management held 10,275 shares of Gilead Sciences worth $1.33M as of Q2 2026.
  • Accurate Wealth Management bought 1,331 Gilead Sciences shares in Q2 2026, an estimated $175K.
  • Gilead Sciences made up 0.13% of Accurate Wealth Management's portfolio in Q2 2026, its #177 holding.
  • Accurate Wealth Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Accurate Wealth Management's Gilead Sciences position peaked at $3.19M in Q3 2022.
  • 837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.